1、 SONG Y, ZHAO C, DONG L, et al. Overexpression of cyclin B1 in human esophagealsquamous cell carcinoma cells induces tumor cell invasive growth andmetastasis[J]. Carcinogenesis, 2008, 29(2):307-315. SONG Y, ZHAO C, DONG L, et al. Overexpression of cyclin B1 in human esophagealsquamous cell carcinoma cells induces tumor cell invasive growth andmetastasis[J]. Carcinogenesis, 2008, 29(2):307-315.
2、 JEFFERY J, SINHA D, SRIHARI S, et al. Beyond cytokinesis:the emerging roles of CEP55 in tumorigenesis[J]. Oncogene, 2016,35(6):683-690. JEFFERY J, SINHA D, SRIHARI S, et al. Beyond cytokinesis:the emerging roles of CEP55 in tumorigenesis[J]. Oncogene, 2016,35(6):683-690.
3、 XUE D, CHENG P, HAN M J, et al. An Integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer [J]. Onco Targets Ther, 2018,10(11):4755-4768. XUE D, CHENG P, HAN M J, et al. An Integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer [J]. Onco Targets Ther, 2018,10(11):4755-4768.
4、 CHRISTOPHER J G, ANN L, JOAN C S, et al. MELK expression correlates with tumormitotic activity but is not required forcancer growth[J]. ELife, 2018,8(7):e32838. CHRISTOPHER J G, ANN L, JOAN C S, et al. MELK expression correlates with tumormitotic activity but is not required forcancer growth[J]. ELife, 2018,8(7):e32838.
5、 ZHANG H Z, REN L L, DING Y, et al. Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGFβ/Smad2-induced epithelial-mesenchymal transition in gastric cancer[J]. ASEB J, 2019,33(5):6365-6377. ZHANG H Z, REN L L, DING Y, et al. Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGFβ/Smad2-induced epithelial-mesenchymal transition in gastric cancer[J]. ASEB J, 2019,33(5):6365-6377.
6、 ZHANG X, PAN Y L,FU H Q, et al. Nucleolar and spindle associated protein 1 (nusap1) inhibits cell proliferation and enhances susceptibility to epirubicin in invasive breast cancer cells by regulating Cyclin D Kinase (CDK1) and DLGAP5 expression[J]. Med Sci Monit, 2018,26(24):8553-8564. ZHANG X, PAN Y L,FU H Q, et al. Nucleolar and spindle associated protein 1 (nusap1) inhibits cell proliferation and enhances susceptibility to epirubicin in invasive breast cancer cells by regulating Cyclin D Kinase (CDK1) and DLGAP5 expression[J]. Med Sci Monit, 2018,26(24):8553-8564.
7、 ENGSTR M J, YTTERHUS B, VATTEN L J, et al. TOP2A gene copy numberchange in breast cancer[J]. J Clin Pathol, 2014, 67(5):420-425. ENGSTR M J, YTTERHUS B, VATTEN L J, et al. TOP2A gene copy numberchange in breast cancer[J]. J Clin Pathol, 2014, 67(5):420-425.
8、 WANG C Q, XIANG F G, LI Y J, et al. Relation between the expression of mitotic centromere-associated kinesin and the progression ofsquamous cell carcinoma of the tongue[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2014,117(3):353-360. WANG C Q, XIANG F G, LI Y J, et al. Relation between the expression of mitotic centromere-associated kinesin and the progression ofsquamous cell carcinoma of the tongue[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2014,117(3):353-360.
9、 ZHANG L Y, SHAO H Y, HUANG Y J, et al. PLK1 phosphorylates mitotic centromere-associated kinesin and promotes its depolymerase activity[J]. J Biol Chem, 2010,286(4):3033-3046. ZHANG L Y, SHAO H Y, HUANG Y J, et al. PLK1 phosphorylates mitotic centromere-associated kinesin and promotes its depolymerase activity[J]. J Biol Chem, 2010,286(4):3033-3046.
10、 SUN B, LIN G, JI D, et al. Dysfunction of sister chromatids separation promotes progression of hepatocellular carcinoma according to analysis of gene expression profiling[J]. Front Physiol, 2018,27(9):1019. SUN B, LIN G, JI D, et al. Dysfunction of sister chromatids separation promotes progression of hepatocellular carcinoma according to analysis of gene expression profiling[J]. Front Physiol, 2018,27(9):1019.
11、 WANG Y, CHENG J, XU C, et al. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma[J]. Liver Int, 2012,32(3):420-428. WANG Y, CHENG J, XU C, et al. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma[J]. Liver Int, 2012,32(3):420-428.
12、 CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China,2015[J]. CA Cancer J Clin, 2016,66(2):115-132. CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China,2015[J]. CA Cancer J Clin, 2016,66(2):115-132.
13、 FREDDIE B, JACQUES F, ISABELLE S, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. FREDDIE B, JACQUES F, ISABELLE S, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424.
14、 MA X J, SONIKA D, ELIZABETH R, et al. Gene expression profiling of the tumor microenvironment during breast cancer progression[J]. Breast Cancer Res, 2009,11(1):R7. MA X J, SONIKA D, ELIZABETH R, et al. Gene expression profiling of the tumor microenvironment during breast cancer progression[J]. Breast Cancer Res, 2009,11(1):R7.
15、 CHRISTINA C, SOHRAB P S, SUET-FEUNG C, et al. The Genomic and transcriptomic architecture of 2 000 breast tumours reveals novel subgroups[J]. Nature, 2012,486(7403):346-352. CHRISTINA C, SOHRAB P S, SUET-FEUNG C, et al. The Genomic and transcriptomic architecture of 2 000 breast tumours reveals novel subgroups[J]. Nature, 2012,486(7403):346-352.
16、 LONG T, LIU Z, ZHOU X, et al. Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis[J]. Mol Med Rep, 2019,19(3):2029-2040. LONG T, LIU Z, ZHOU X, et al. Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis[J]. Mol Med Rep, 2019,19(3):2029-2040.
17、 BRETTHAUER M, KALAGER M. Principles, effectiveness and caveats in screening for cancer[J]. Br J Surg, 2013,100(1):55-65. BRETTHAUER M, KALAGER M. Principles, effectiveness and caveats in screening for cancer[J]. Br J Surg, 2013,100(1):55-65.
18、 FEI W. Current status of breast cancer prevention in China[J]. Chron Dis Transl Med,2015,1(1):2-8. FEI W. Current status of breast cancer prevention in China[J]. Chron Dis Transl Med,2015,1(1):2-8.
